top of page

More Biopharma Stock Ideas from Q3 Hedge Fund Activity

  • Writer: BPIQ
    BPIQ
  • Dec 20, 2023
  • 2 min read

You can find updated Q3 bioHF holdings data at app.bpiq.com/hedgefunds

  • Check out the ticker screener

  • If you are an Elite or Amp subscriber ...

    • Check out the tables at the links on the left menu under "Hedge Funds"

    • If not, sign up today HERE 


Our goal is to help you make $$ investing in biopharma

That's why we follow top biopharma hedge funds (bioHFs) ^1


Here are some tickers to check out based on Q3 hedge fund activity

  • Tickers most initiated or closed by bioHF in Q3 '23

  • Most initiated

    • $RYZB $APGE $TSHE $SGMT $IMVT $SLNO $CMPS $GOSS

  • Most closed

    • $BDTX $VIR $THRX $MRSN


More details ...

👇 Initiated by the most bioHFs in Q3 '23

• Based on 9/30/23 13F filings


⇨ 2 newly IPOed

  • RYZB (10 vs. 0)  (# bioHFs that held ticker on 9/30/23 vs. 6/30/23)

    • 9/19/23 IPO

    • Ph1 SCLC & endocrine tumors

    • RYZB pipeline


  • APGE (9 vs. 0)

    • 7/13/23 IPO

    • Ph1 Atopic derm

    • APGE pipeline


⇨ 1 more with very early stage assets

  • TSHA (8 vs. 0)  (^2)

    • Ph1/2 Rett Syndrome

  • TSHA pipeline


⇨ 1 whose stock took a big plunge since end of Q3

  • SGMT (5 vs. 0)

    • Stock heading down since end Q2 (~12.50 to ~$3.63) but no readouts?

    • Upcoming Ph2b catalyst (Q1 2024) in  NASH

  • SGMT 1 yr stock chart


⇨ 2 that had big mover positive readouts near end of last quarter

  • IMVT (14 vs. 6)

    • 9/26/23

    • Ph1 auto-immune disease

    • IMVT-14-2 anti-FcRn Ab for various auto-immune diseases

    • pipeline in asset-type asset

    • IMVT 1 yr stock chart


  • SLNO (7 vs. 1)

    • 9/26/23

    • Ph3 in PWS (rare disease - hyperphagia - eating disorder)

    • SLNO 1 yr stock chart


⇨ 1 with an important upcoming readout

  • CMPS (7 vs. 1)

    • Ph3 depression - Summer 2024

    • Only Deep Track had it previously

    • CMPS pipeline


⇨ 1 whose stock was crushed at end of 2022

  • GOSS (10 vs 5)

    • Lots of bioHFs for a micro-cap

      • EV <$200M

      • 4 top 20s is high too

      • Ph2 update 12/18/23 for only clinical asset

  • GOSS stock chart



👇 As far as bioHF positions closed,

  • Not as many closed as initiated


⇨ Most bioHF closed in Q3 '23

  • Positions closed by 3 HFs

    • BDTX (5 vs. 8)

    • VIR (2 vs. 5)

    • THRX (3 vs. 6)

    • MRSN (8 vs. 11)



SUMMARY

  • These tickers are good ones to dig deeper into

  • Or if you already hold these tickers

  • take the info above as reinforcing, or a caution



^1 We identified & follow moves of 36 top BioHFs

⇨ That focus on biopharma stocks & have over $250M in AUM

^2 Confirm with your Hedge Fund data provider that there were no holdings for this ticker in Q2 to assure our provider's data is accurate, since the move from 0 to 8 is quite unusual for a company that went public before Q2



This article is not investment, tax, or legal advice. Please do your own diligence and seek advice from professional advisors representing your interests.  


Article history:

Posted 12/20/23 (EJV)


 
 
 

Comments


bottom of page